Meet Pelago Bioscience at ELRIG Research & Innovation 2025
Pelago Bioscience is excited to participate in ELRIG Research & Innovation 2025, which will be held on March 10–11 at the Royal Society of Medicine in London. This event brings together experts fr...
Join us at US Drug Discovery Innovation Programme 2025
We are attending the US Drug Discovery Innovation Programme 2025 in San Diego, March 3–4, where industry leaders will gather to explore the latest advancements in drug discovery. Meet our team a...
Webinar: Applying CETSA® to Translational Studies – A Sitryx Story
Bridging the Gap Between In Vitro and In Vivo with CETSA 4 March 2025 17:00 CET | 16:00 GMT | 11:00 EST | 08:00 PST Missed the Webinar? We’ve Got You Covered! If you missed it, don’t worry! We’l...
Let’s Connect at EFMC-ISCB 2025, Basel
We are attending EFMC-ISCB 2025 in Basel, January 29 to 31, and we’re excited to meet you there. Stop by Booth #8 to connect with our team, including Laurence Arnold (Head of R&D), Mitko Dimitrov ...
The Koehler Lab at MIT acknowledges Pelago Bioscience’s patent and use of CETSA® process
Pelago Bioscience celebrates that the Koehler Lab at the Massachusetts Institution of Technology found CETSA® to be a valuable method for quantifying drug Target Engagement in the lab’s experiments de...
We’re attending SLAS 25
Meet us on January 25-29, San Diego Convention Center San Diego, CA (USA). Don’t miss our poster presentation: Title: Enhancing degrader research with CETSA.Date: January 28thTime: 2:00–3:00 pm Meet o...
University of Southampton acknowledges Pelago Bioscience’s patent and use of CETSA® process
Pelago Bioscience is excited about University of Southampton researchers, led by Professor Tavassoli, having found our patented CETSA® technology useful in their research into identifying hypoxia-indu...
Join our Webinar
How CETSA® has been applied in Lead Generation delivering novel modulators of PLCγ2 4 December 2024 17:00 CET | 16:00 GMT | 11:00 EST | 08:00 PST Featured Speaker Fiona Jeganathan Head of Pharmac...
Meet us at BIO-Europe 2024
November 4-6, Stockholmsmässan | Stockholm – Sweden. Our CEO, Michael Dabrowski along with Regional Sales Manager Marianne Alksnis and Head of Sales Magnus Lejelöv, will be attending the Europe&...
Find us at 7th Annual TPD & Induced Proximity Summit
October 28-31, The Westin Copley Place | Boston – MA (US). We are attending the 7th TPD & Induced Proximity Summit, in Boston.Meet our Head of Sales North America, Brian Jarecki, and team at...
New privacy policy
We respect your integrity and ensure that your personal data is processed with the confidentiality and respect that is required. Therefore, We have revised our privacy policy.
We’re attending MSD Technology Symposium
Meet us on September 24-25, Greater Philadelphia Expo Center, Oaks, PA (US). New service Learn more about or latest contribution to our service portfolio; Standard Selectivity Profiling, by attending ...
Meet us at Discovery on Target
September 30 – October 3 we are attending the 22nd Discovery on Target conference, in Boston. Meet our Head of Sales North America, Brian Jarecki, and team. They will tell you all about how we c...
Pelago Bioscience AB signs strategic agreement with Cancer Research Horizons
Pelago Bioscience AB signs a strategic agreement with Cancer Research Horizons to unlock quantitative assessment of cellular target engagement across its pipeline of novel oncology programmes. The com...
BellBrook Labs acknowledges Pelago Bioscience’s patent and use of CETSA® process
In connection with the CETSA platform, the BellBrook Labs, LLC states: “BellBrook Labs wishes to acknowledge the validity of Pelago Biosciences patented and trademarked CETSA technology (US Pat. Nos. ...
University of Edinburgh acknowledges Pelago Bioscience’s patent and use of CETSA® process
In connection with the CETSA platform, the University of Edinburgh states: “The University of Edinburgh wishes to acknowledge the validity of Pelago’s CETSA patent (EP 2 699 910 B1) entitled “Methods ...